Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Current Deferred Revenue (2016 - 2026)

Ekso Bionics Holdings has reported Current Deferred Revenue over the past 13 years, most recently at $1.7 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 11.71% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 11.71% decrease, with the full-year FY2025 number at $1.7 million, down 11.71% from a year prior.
  • Current Deferred Revenue reached $1.7 million in Q4 2025 per EKSO's latest filing, up from $1.7 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $2.1 million in Q3 2022, with the low at $1.1 million in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $1.7 million (2023), against an average of $1.6 million.
  • Peak YoY movement for Current Deferred Revenue: crashed 63.05% in 2021, then skyrocketed 77.79% in 2023.
  • Tracing EKSO's Current Deferred Revenue over 5 years: stood at $1.2 million in 2021, then dropped by 8.11% to $1.1 million in 2022, then skyrocketed by 77.79% to $2.0 million in 2023, then fell by 1.86% to $2.0 million in 2024, then dropped by 11.71% to $1.7 million in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $1.7 million, $1.7 million, and $1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.